In addition, we observed a trend toward a higher incidence of high NAT10 expression among colon cancer patients with positive PD-L1 expression, despite the lack of statistical significance (Additional file 1: Fig. S3B). This evidence concerns the gene CD274 and malignant colon neoplasm.